SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-017368
Filing Date
2022-08-15
Accepted
2022-08-15 16:06:01
Documents
49
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q prds-20220630.htm   iXBRL 10-Q 1986069
2 EX-31.1 prds-ex31_1.htm EX-31.1 21178
3 EX-31.2 prds-ex31_2.htm EX-31.2 21254
4 EX-32 prds-ex32.htm EX-32 20553
  Complete submission text file 0000950170-22-017368.txt   5244856

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prds-20220630_pre.xml EX-101.PRE 305444
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prds-20220630_def.xml EX-101.DEF 181723
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prds-20220630.xsd EX-101.SCH 54781
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prds-20220630_lab.xml EX-101.LAB 414719
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prds-20220630_cal.xml EX-101.CAL 29373
43 EXTRACTED XBRL INSTANCE DOCUMENT prds-20220630_htm.xml XML 424634
Mailing Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008 415-649-8758
PARDES BIOSCIENCES, INC. (Filer) CIK: 0001822711 (see all company filings)

IRS No.: 852696306 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40067 | Film No.: 221165644
SIC: 2834 Pharmaceutical Preparations